White label ELPA - ClinicalTrials.eu

Study on the Effects of Filgotinib for Children and Teenagers with Moderate to Severe Ulcerative Colitis

Recruiting

3 1 1 1
Investigated Diseases:
- Colitis ulcerative
Investigated Drugs:
- Filgotinib
+6
Study of Vedolizumab for Children with Moderate to Severe Ulcerative Colitis or Crohn’s Disease

Recruiting

3 1 1 1
Investigated Diseases:
- Colitis ulcerative
- Crohn’s disease
Investigated Drugs:
- Vedolizumab
+4
Study on Valsartan for Slowing Aortic Root Dilatation in Children and Young Adults with Marfan Syndrome and Related Conditions

Recruiting

3 1 1
Investigated Diseases:
Investigated Drugs:
- Valsartan
Study of Lutikizumab, ABBV-382, and Risankizumab for Adults with Moderate to Severe Crohn’s Disease

Recruiting

2 1 1
Investigated Drugs:
+17
Study on Azithromycin for Treating Hospitalized Children Aged 1-5 with Asthma Symptoms

Recruiting

2 1 1
Investigated Drugs:
Study of elacestrant and ribociclib compared to standard treatment for patients with high-risk ER+/HER2- early breast cancer

Recruiting

3 1 1 1
Investigated Drugs:
- Elacestrant
- Ribociclib
A study to evaluate the efficacy and safety of depemokimab and salbutamol sulfate in patients with chronic obstructive pulmonary disease and type 2 inflammation.

Recruiting

3 1 1
Investigated Drugs:
- Depemokimab
- Salbutamol Sulfate
+6
A Phase III Study of Elafibranor in Adults with Primary Sclerosing Cholangitis to Assess Efficacy and Safety

Recruiting

3 1
Investigated Diseases:
- Cholangitis sclerosing
Investigated Drugs:
- Elafibranor
+9
A study of MK-1084 and a drug combination for patients with advanced or metastatic non-small cell lung cancer with KRAS G12C mutations.

Recruiting

1 1 1 1
Investigated Diseases:
- Non-small cell lung cancer
Investigated Drugs:
Effect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)

Recruiting

3 1 1
Investigated Diseases:
- Heart failure with preserved ejection fraction
Investigated Drugs:
- Azd5004
- Dapagliflozin
+8

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies